These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33086204)

  • 1. Differentiating cancer types using a urine test for volatile organic compounds.
    Bannaga AS; Kvasnik F; Persaud K; Arasaradnam RP
    J Breath Res; 2020 Dec; 15(1):017102. PubMed ID: 33086204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary volatile compounds as biomarkers for lung cancer.
    Hanai Y; Shimono K; Matsumura K; Vachani A; Albelda S; Yamazaki K; Beauchamp GK; Oka H
    Biosci Biotechnol Biochem; 2012; 76(4):679-84. PubMed ID: 22484930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
    Silva CL; Passos M; Câmara JS
    Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
    Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
    Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of volatile organic compounds with a wide range of polarities in urine by headspace solid-phase microextraction coupled to gas chromatography/mass spectrometry.
    Song HN; Kim CH; Lee WY; Cho SH
    Rapid Commun Mass Spectrom; 2017 Apr; 31(7):613-622. PubMed ID: 28085216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
    Zhang S; Raftery D
    Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of headspace SPME method for analysis of volatile organic compounds present in human biological specimens.
    Kusano M; Mendez E; Furton KG
    Anal Bioanal Chem; 2011 Jun; 400(7):1817-26. PubMed ID: 21598081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
    Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
    Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary volatile organic compounds in overweight compared to normal-weight children: results from the Italian I.Family cohort.
    Cozzolino R; De Giulio B; Marena P; Martignetti A; Günther K; Lauria F; Russo P; Stocchero M; Siani A
    Sci Rep; 2017 Nov; 7(1):15636. PubMed ID: 29142292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
    Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
    Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of an SPME fiber based on ZnO@GA nanorods coated onto fused silica as a highly efficient absorbent for the analysis of cancer VOCs in water and urine.
    Naseri N; Kharrazi S; Abdi K; Alizadeh R
    Anal Chim Acta; 2021 Oct; 1183():338983. PubMed ID: 34627504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
    Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
    Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.